BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6259207)

  • 1. Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis.
    Ferrell PB; Aitcheson CT; Pearson GR; Tan EM
    J Clin Invest; 1981 Mar; 67(3):681-7. PubMed ID: 6259207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
    Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
    Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
    Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
    J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
    Joncas JH; Wills A; Reece E; Fox Z
    Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-related antibody pattern in uveitis.
    Sunakawa M; Okinami S
    Jpn J Ophthalmol; 1985; 29(4):423-8. PubMed ID: 3007826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study on antibodies against EBV in sera of patients with rheumatoid arthritis].
    Zhang X; Li B; Liu Y; Jiang M
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Feb; 21(1):8-12. PubMed ID: 12569633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
    Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-related antibody patterns in ataxia-telangiectasia.
    Berkel AI; Henle W; Henle G; Klein G; Ersoy F; Sanal O
    Clin Exp Immunol; 1979 Feb; 35(2):196-201. PubMed ID: 219976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of immune complexes in rheumatoid arthritis for Epstein-Barr virus antigens reveals cross-reactivity of viral capsid antigen and human IgG.
    Inman RD; Chiu B; Hamilton NC
    J Immunol; 1987 Jan; 138(2):407-12. PubMed ID: 3025298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
    Kuljić-Kapulica N
    Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to synthetic peptides from Epstein-Barr nuclear antigen-1 in sera of patients with early rheumatoid arthritis and in preillness sera.
    Kouri T; Petersen J; Rhodes G; Aho K; Palosuo T; Heliövaara M; Isomäki H; von Essen R; Vaughan JH
    J Rheumatol; 1990 Nov; 17(11):1442-9. PubMed ID: 2177109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Strict correlation between anti-RANA antibodies and anti-EBNA antibodies apart from rheumatoid arthritis. Assessment of the diagnostic value of anti-RANA antibody].
    Cohen JH; Lenoir GM; Colmet-Daage JF; Blanchard F; Etienne JC; Dropsy G; Gougeon J
    Rev Rhum Mal Osteoartic; 1983 Jan; 50(1):3-7. PubMed ID: 6302824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
    Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome.
    Jones JF; Williams M; Schooley RT; Robinson C; Glaser R
    Arch Intern Med; 1988 Sep; 148(9):1957-60. PubMed ID: 2843138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis.
    Alspaugh MA; Henle G; Lennette ET; Henle W
    J Clin Invest; 1981 Apr; 67(4):1134-40. PubMed ID: 6259211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus antibodies in patients with laryngeal and hypopharyngeal cancer.
    Morshed K; Polz-Dacewicz M; Szymański M; Rajtar B; Ziaja-Sołtys M; Gołabek W
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):227-31. PubMed ID: 15323196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis.
    Pratesi F; Tommasi C; Anzilotti C; Chimenti D; Migliorini P
    Arthritis Rheum; 2006 Mar; 54(3):733-41. PubMed ID: 16508937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
    O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
    J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.